Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Universal Health Services (UHS)

NYSE Health Care Health Care Facilities S&P 500
$195.50
-3.09 (-1.56%)
Close of Nov 06, 2026 · end-of-day data
Source: Universal Health Services's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$9.77B$10.41B$10.77B$11.38B$11.56B$12.64B$13.40B$14.28B$15.83B$17.36B
Operating income$1.28B$1.28B$1.18B$1.22B$1.36B$1.36B$1.00B$1.18B$1.68B$1.99B
Interest expense$125.05M$145.17M$154.96M$162.73M$106.28M$83.67M$126.89M$206.67M$186.11M$156.07M
Pre-tax income$1.16B$1.14B$1.03B$1.07B$1.25B$1.29B$866.26M$940.43M$1.50B$1.97B
Income tax$409.19M$363.70M$236.64M$238.79M$299.29M$305.68M$209.28M$221.12M$334.83M$460.96M
Net income$702.41M$752.30M$779.71M$814.85M$943.95M$991.59M$675.61M$717.79M$1.14B$1.49B
EBITDA$1.70B$1.73B$1.63B$1.71B$1.87B$1.90B$1.59B$1.74B$2.27B$2.61B
EPS (basic)$7.22$7.86$8.35$9.16$11.06$11.99$9.23$10.35$17.16$23.42
EPS (diluted)$7.14$7.81$8.31$9.13$10.99$11.82$9.14$10.23$16.82$23.10
Diluted shares98.38M96.33M93.75M89.04M85.59M83.69M73.83M70.12M67.90M64.46M
Operating margin13.1%12.3%10.9%10.7%11.8%10.8%7.5%8.2%10.6%11.5%
Net margin7.2%7.2%7.2%7.2%8.2%7.8%5.0%5.0%7.2%8.6%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$33.75M$74.42M$105.22M$61.27M$1.22B$115.30M$102.82M$119.44M$125.98M$137.80M
Receivables$1.44B$1.50B$1.51B$1.56B$1.73B$1.75B$2.02B$2.24B$2.18B$2.60B
Total current assets$1.68B$1.80B$1.94B$1.92B$3.28B$2.26B$2.54B$2.81B$2.82B$3.41B
Goodwill$3.78B$3.83B$3.84B$3.87B$3.88B$3.96B$3.91B$3.93B$3.93B$3.99B
Total assets$10.32B$10.76B$11.27B$11.67B$13.48B$13.09B$13.49B$13.97B$14.47B$15.53B
Total current liabilities$1.32B$1.85B$1.45B$1.56B$2.48B$1.98B$1.91B$2.01B$2.21B$3.24B
Short-term debt$105.89M$545.62M$63.45M$87.55M$332.00M$48.41M$81.45M$126.69M$40.06M$748.16M
Long-term debt$4.03B$3.49B$3.94B$3.90B$3.52B$4.14B$4.73B$4.79B$4.46B$4.00B
Total debt$4.14B$4.04B$4.00B$3.98B$3.86B$4.19B$4.81B$4.91B$4.50B$4.75B
Total liabilities$5.78B$5.77B$5.88B$6.16B$7.16B$7.00B$7.57B$7.82B$7.80B$8.25B
Shareholders' equity$4.53B$4.99B$5.39B$5.50B$6.32B$6.09B$5.92B$6.15B$6.67B$7.28B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.33B$1.25B$1.27B$1.44B$2.36B$883.70M$996.02M$1.27B$2.07B$1.86B
Capital expenditures$519.94M$557.51M$664.96M$634.10M$731.31M$855.66M$734.00M$743.05M$943.81M$1.02B
Free cash flow$813.90M$690.08M$609.78M$804.37M$1.63B$28.04M$262.02M$524.74M$1.12B$849.25M
Investing cash flow-$1.16B-$684.73M-$747.25M-$688.41M-$802.56M-$914.47M-$647.30M-$763.27M-$911.11M-$1.07B
Financing cash flow-$171.17M-$519.15M-$492.20M-$845.04M-$384.86M-$1.07B-$318.40M-$493.94M-$1.14B-$749.73M
Dividends paid$38.88M$38.21M$37.34M$53.00M$17.34M$65.90M$58.45M$55.48M$53.35M$51.27M
Share buybacks$353.38M$364.40M$397.43M$770.50M$206.72M$1.22B$832.92M$547.36M$670.75M$967.95M
Stock-based compensation$48.11M$56.74M$66.58M$69.43M$65.84M$73.69M$85.38M$87.72M$99.35M$95.69M
Depreciation & amortization$416.61M$447.76M$453.05M$490.39M$510.49M$533.21M$581.86M$568.04M$584.83M$618.74M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.